TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
0.9410
-0.0161 (-1.68%)
Apr 17, 2025, 4:00 PM EDT - Market closed
TELA Bio Stock Forecast
TELA's stock price has decreased by -81.07% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts with 12-month price forecasts for TELA Bio stock have an average target of 6.00, with a low estimate of 2.00 and a high estimate of 8.00. The average target predicts an increase of 537.62% from the current stock price of 0.94.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 21, 2025.
Analyst Ratings
The average analyst rating for TELA Bio stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $12 → $7 | Strong Buy | Maintains | $12 → $7 | +643.89% | Mar 21, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Maintains $12 → $7 | Buy | Maintains | $12 → $7 | +643.89% | Mar 21, 2025 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $5 → $2 | Buy → Hold | Downgrades | $5 → $2 | +112.54% | Mar 21, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $8 → $5 | Buy | Maintains | $8 → $5 | +431.35% | Nov 8, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $12 | Strong Buy | Maintains | $12 | +1,175.24% | Oct 4, 2024 |
Financial Forecast
Revenue This Year
87.25M
from 69.30M
Increased by 25.90%
Revenue Next Year
107.31M
from 87.25M
Increased by 23.00%
EPS This Year
-0.66
from -1.33
EPS Next Year
-0.37
from -0.66
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 90.6M | 114.5M | 141.8M | |
| Avg | 87.2M | 107.3M | 130.1M | |
| Low | 83.1M | 99.6M | 117.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 30.8% | 31.3% | 32.1% | |
| Avg | 25.9% | 23.0% | 21.2% | |
| Low | 19.9% | 14.1% | 9.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -0.47 | -0.11 | 0.30 | |
| Avg | -0.66 | -0.37 | 0.15 | |
| Low | -0.84 | -0.64 | 0.01 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.